What's in Wilbur Chen, MD, MS's pipeline?

Wilbur Chen, MD, MS has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Wilbur Chen, MD, MS's portfolio?

Top competitors by shared drug class: Bharat Biotech International Limited, Boryung Pharmaceutical Co., Ltd, Centers for Disease Control and Prevention, Chiang Mai University, China National Biotec Group Company Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/wilbur-chen-md-ms.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Wilbur Chen, MD, MS — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wilbur Chen, MD, MS pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
HDCV Comparator	HDCV Comparator	phase 3	Inactivated viral vaccine	Rabies virus glycoprotein	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bharat Biotech International Limited · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Centers for Disease Control and Prevention · 1 shared drug class
Chiang Mai University · 1 shared drug class
China National Biotec Group Company Limited · 1 shared drug class
Clover Biopharmaceuticals AUS Pty · 1 shared drug class
Cogna Technology Solutions LLC · 1 shared drug class
AJ Vaccines A/S · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Wilbur Chen, MD, MS:

Cite this brief

Drug Landscape (2026). Wilbur Chen, MD, MS — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/wilbur-chen-md-ms. Accessed 2026-06-10.